Campylobacter species are primarily zoonotic pathogens and recognized as a major cause of human illnesses. Poultry, especially, chicken is the main reservoir of Campylobacter species. The uncontrolled use of antibiotics in prophylaxis and treatment of animals caused an increase in antibiotic resistance to macrolides and fluoroquinolones (FQ) which are considered the drugs of choice for treatment of Campylobacter infection. Recently, studies suggested that multidrug efflux systems have the main role in lowering the efficacy of new and old antibiotics. Consequently, efforts are made to find suitable substances to reverse the action of the efflux pumps and prevent antimicrobial resistance. The substances used for evaluation of efflux pumps modulation are either efflux pump inhibitors (EPIs) or efflux pump inducers. The different types of EPIs; phenylalanine arginyl β-naphthylamide, verapamil and phenothiazines, of different mode of actions were used to suppress the activity of different types of efflux pumps. Aspirin, a drug in livestock and poultry, is a nonsteroidal anti-inflammatory, which induces non-heritable resistance of different bacteria to multiple antibiotics. Moreover, it also increases campylobacter resistance to antimicrobials. Alpha-tocopherol represents a new alternative approach against bacterial resistance. It shows modulatory activity on efflux system, showing clinically relevant results. Therefore, it is important to study different resistance mechanisms of campylobacters.
Introduction
Thermophilic Campylobacter species were implicated in several foodborne infections. C. jejuni is most frequently reported as a cause of human campylobacteriosis (80-90%) compared to C. coli (5-10%) [1] . Campylobacters are long spiral forms, curved, atypical Gram-negative rods [2] , motile by means of a single polar unsheathed flagellum at one or both ends giving it the characteristic cork-screw motility [3] . All campylobacters grow mainly under microaerobic (3-10% O 2 ) and capnophilic conditions (10% CO 2 ) at 37ºC, but for the thermophilic species; C. jejuni, C. coli, C. lari, C. hyointestinalis subspp. hyointestinalis and C. upsaliensis the optimum temperature is 42ºC [4] . This temperature is essential for growth adaptation in the intestines of warm-blooded birds and mammals [5] . Hippurate hydrolysis is the only phenotypic test differentiating C. jejuni from other species of campylobacters [6] . The two biotypes of C. jejuni are capable of hydrolyzing sodium hippurate to benzoic acid and glycine [7] . However, recently, false hippurate negative and positive C. jejuni strains have been reported in several studies [8] [9] [10] The chicken gut especially the caeca is often colonized by campylobacters especially C. jejuni [1] . Consequently, chicken meat and products can be contaminated during processing and are considered the main source of campylobacteriosis in humans [11] .
Campylobacteriosis in chickens is mainly a commensal infection [12] . It can infect chickens at young ages and defecation spreads the pathogen among the entire flock, but not before two weeks of age due to maternal antibody protection [13] . Once a bird is infected, the majority (> 95%) of the flock will be colonized by enteric campylobacters within several days and remain infected for life [14] .
Campylobacters were recognized as a major cause of human illnesses ranging from acute diarrheal disease to sever illness; Guillain-2 Barre Syndrome [15] . They are naturally susceptible to several antimicrobial agents including fluoroquinolones (FQ) and macrolides which are considered the drugs of choice for infection treatment [16] . However, macrolide and FQ resistance, was recently documented to increase in several countries [17, 18] . This is attributed to misuse of antibiotics in the animal husbandry and human population [19] . A unique restriction modification system which may decrease the uptake of foreign genetic material have been identified in Campylobacters, however, the acquisition of resistance genes from other microorganisms has been reported [20] .
Therefore, studying different resistance mechanisms in Campylobacter spp. is important for human health.
Antimicrobial resistance

Fluoroquinolones
Classification
Quinolones are synthetic compounds with bactericidal activity. They became a widely used class of antimicrobials and divided into four groups according to their spectrum of activity (Table 1) [21]. 
Mechanism of action
The targets of quinolone action are two large bacterial enzymes; i) DNA gyrase which has two A and two B subunits encoded by the gyrA and gyrB genes, respectively [22] . In addition to, ii) topoisomerase IV which has two pairs of subunits encoded by parC and parE [23] . Both enzymes act together on bacterial DNA synthesis [24] , quinolones inhibit the DNA synthesis of the bacteria by acting on both enzymes leading to cell death [25] .
Resistance mechanism
In Gram negative bacteria, the mechanisms causing resistance to fluoroquinolones included target mutations or increased efflux activity [24, 26] . Also, the target protection by inactivating enzymes mediated by the Plasmid Mediated Quinolone Resistance (PMQR) mechanisms; the qnr genes, are reported [27] . These genes produce proteins which protect the DNA gyrase or topoisomerase IV enzymes from the inhibitory effect of fluoroquinolones. Additional Another mechanism of fluoroquinolones resistance efflux; it was reported in 1995 [37, 38] . Efflux pumps are protein complexes located in the bacterial cell membrane and they expel antimicrobials and toxins, lowering their concentration inside the bacterial cell to sub-toxic levels. Thus, giving them the time needed to acquire resistance through more specific adaptive mechanisms [39] [40] [41] . These proteins recognize and remove a wide range of antimicrobials of different mechanisms and sites of action. These pumps are also important for bacterial pathogenesis, virulence and biofilm formation [42] [43] [44] . Bacterial efflux pumps (Figure 1) The RND efflux system; cmeABC, was identified and characterized in C. [59] . Therefore, cmeR controls the expression of two types of efflux pumps; RND and MFS superfamily in campylobacters. Recently, certain substrates such as bile salts and salicylate have been reported to interact with cmeR and induce the expression of the cmeABC efflux system, therefore, it is called efflux inducers [60, 61] . The second transcriptional regulator for cmeABC is cosR, which is the key regulator for oxidative stress response in campylobacters [62] . The cosR binds to a site which is 17 bp upstream of the cmeR binding site in the promoter region of cmeABC and represses the expression of this efflux operon [62] . In addition, cosR is predicted to be a response regulator of a twocomponent regulatory system, and its inhibition led to overexpression of cmeABC [62] . These findings suggest that oxidative stress response and the antibiotic efflux system are interactive in C. jejuni, and cosR plays a bridging role in the interaction [54] .
Another RND-type efflux pump identified in C. jejuni is cmeDEF, the cmeD is an outer membrane protein that shares low, but significant sequence homology with those in H. pylori and E. coli [55] The same features of cmeG are shared with those of MFS efflux pumps in other bacteria which suggest that cmeG may act as a multidrug efflux pump in campylobacters, and also plays an important role in campylobacter resistance to oxidative stress [63] . The expression of cmeG appears to be regulated by Fur protein and iron concentrations for inactivation of Fur or depleting iron resulted in up-regulated expression of cmeG [64, 65] . The transcription of cmeG occurred together with its downstream gene cmeH, which is not present in all C. jejuni strains. The cmeH encodes a putative periplasmic protein with has sequence similarity to B. subtilis yuiI and Salmonella enterica iroE [49] . These proteins are associated with siderophore uptake in these bacteria [66] . The mutations in cmeH not affect its resistance to antimicrobial agents, suggesting that cmeH alone does not have a role in antimicrobial resistance. Meanwhile, fluoroquinolones resistance was significantly increased in C. jejuni with overexpressed cmeGH operon. In addition, ciprofloxacin was more accumulated in strains with mutant cmeG than the wild type strain [63] .
Fluoroquinolones cause bacterial death by forming a stable complex with gyrases and DNA [22] . However, antibiotic treatments induce the SOS response in some bacteria. This response upregulates many genes involved in DNA repair, recombination and mutation. These genes are also involved in other functions such as drug resistance development, virulence factors production and horizontal transfer of genetic materials [67, 68] . Han [69] , in the presence and absence of ciprofloxacin, compared the different gene expression profiles of C. jejuni using DNA microarray. The results showed that multiple genes were significantly changed in their expression in the presence of ciprofloxacin with subtherapeutic concentrations. The mfd (mutation frequency decline) gene was one of these up-regulated genes, which is involved in DNA repair [70, 71] . Mutation of this gene resulted in reduction in the spontaneous mutation rate to ciprofloxacin resistance with 100 fold approximately, while, mfd gene overexpression elevated the mutation frequency [69] . In addition, the development of fluoroquinolone resistant C. jejuni in culture media or chickens treated with fluoroquinolones was significantly reduced by lossing mfd gene. Thus, indicating the impotant role of mfd in the development of quinolone resistance in campylobacters [69] . Campylobacters may not have the typical SOS response system and the error-prone DNA polymerases [69] . Thus, mfd as an alternative pathway for increasing mutation rates may be used by C. jejuni when imposed by FQ treatment [69] .
Macrolides
Classification
The macrolides are group of antibiotics that inhibit protein synthesis. Erythromycin is the first natural macrolide discovered at 1952 in Streptomyces erythreus. This class includes also azithromycin, clarithromycin, telithromycin (ketolide) and two veterinary drugs namely, tylosin and tilmicosin. All macrolide compounds share a lactone ring, and according to this ring structure, they can be divided into either 14-, 15-, or 16-membered compounds [72] .
Mechanism of action
Macrolides bind reversibly to bacterial ribosomes at the P site on the 50s subunit leading to inhibition of bacterial protein synthesis [73] . The key nucleotides contact sites at which macrolide binds mainly are Ala 2058 and Ala 2059 at which macrolides bind and terminate the elongation of the synthetizing peptide chain [74] .
Resistance mechanism
Four macrolide resistance mechanisms were identified; including; target sites modification by mutation or methylation, antibiotic inactivation, active antibiotic efflux and altered membrane permeability [75] . There are three copies of 23S rRNA gene in C. jejuni and C. coli. In macrolide resistant strains, three copies are usually mutated (homozygous mutation) [49] . Mutations at the positions 2074 or 2075 of the 23S rRNA gene cause high level of resistance to macrolides with the 2075 substitution being more common [76, 77] . However, some strains with low macrolides resistance were found to have mutation in one gene copy (heterozygous mutation), suggesting a dose effect of the gene [78] . However, there are no reports of macrolide-resistant campylobacter strains containing only one mutated copy of the 23S rRNA gene [76, 79] . In addition, the resistance may be caused by posttranslational modifications of the ribosomal proteins L 4 and L 22 [80] [81] [82] .
Erythromycin is an antibiotic synthesized by the Gram-positive bacterium Streptomyces erythreus, which protects its own ribosomes by expression of a methyltransferase; ermE, that specifically modifies nucleotide A2058 within 23S rRNA [83] .
Enzyme-mediated methylation (erm) genes, can cause macrolide resistance, however, it has been only reported in Campylobacter rectus [84] . Recently, Qin [75] identified the first horizontally transferrable macrolide resistance mechanism in C. coli isolated from porcine. This resistance mechanism is mediated by a ribosomal RNA methylase, erm(B), which is 738 bp in length and has 100% similarity to the ermB genes identified in Streptococcus suis, Enterococcus faecium and Lactobacillus plantarum plasmid pLFE1, in which, this gene alone was responsible for the high level of macrolide resistance [75] .
The third mechanism of macrolide resistance is the alteration of membrane permeability which is mediated by expression of the major outer membrane porin (MOMP) and chromosomally encoded by porA [ [115, 116] . Therefore, its inhibition mechanism was proposed to be acting on MFS and ABC substrates [114, [117] [118] [119] [120] .
Alpha-tocopherol is an isoform of vitamin E and characterizes by a lipophilic character which permits the perturbations in cell membrane, leading to damage of the membrane integrity and followed by the collapse of pumps [121, 122] . In vitro, it showed a modulatory effect in Gram-negative strains mainly with high level of aminoglycosides resistance. That effect may be due to composition of Gram-negative bacteria which are characterized by higher amount of lipids than Gram-positive bacteria. Therefore, the greater effect of alphatocopherol [123] [124] [125] is modulating E. coli and P. aeruginosa more effectively, when compared with S. aureus [126] . It represents a new approach against microbial resistance [126] .
Different types of inducers such as salicylate and bile salts can be used. The principal metabolites of aspirin (acetylsalicylic acid) are salicylic acid and salicylate [127] , and it is a nonsteroidal anti-inflammatory drug (NSAID) widely used in livestock animals and poultry [128] . It suppresses the normal functioning of platelets. Aspirin is naturally stable in dry atmosphere, but when contact with moisture it is hydrolysed to salicylic acids and acetic acid [129] . Also, the salicylic acid is widely distributed in foods, plants and beverages [130, 131] . Thus, salicylate can reach humans and food producing animals through different sources. Regarding the great effect of salicylate on mammalian cells, it affects the susceptibility of bacteria to different groups of antibiotics.
That effect occurs due to growth of bacteria in the presence of salicylate around, inducing non-heritable resistance to various groups of antibiotics [132] . Moreover, the resistance pattern of campylobacters is increased to antibiotics in presence of salicylate [61] . Salicylate decreases antibiotics susceptibility by two different mechanisms of actions. Firstly, it may induce over expression of cmeABC by binding to cmeR and inhibiting its action to cmeABC leading to an increase in resistance to antibiotics especially ciprofloxacin and thus increasing emergence of fluoroquinolone resistant mutation [61] . Secondary, it alters membrane proteins, induces efflux pumps and decreases the susceptibility of certain bacteria such as E. coli [132] . C. jejuni has an outer-membrane porin (MOMP) [133] and multidrug efflux pump (cmeABC) belonging to the same families in E. coli [37] . This may suggest that salicylate could decrease the susceptibility of antibiotics by decreasing antibiotic accumulation in campylobacter cells. Previous studies; Randall [134] and Hannula and Hänninen [92] reported that salicylate induced a significant increase in resistance to ciprofloxacin and erythromycin in most of the examined campylobacter strains. 
Incidence of resistance in Egypt
Although campylobacteriosis is endemic in Egypt and considered a major cause for pediatric diarrhea [135] , fluoroquinolone and macrolide resistance, was recently documented to increase in the isolated strains in Egypt [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] . In the period from 1991 to 2016, several studies screened and analyzed the resistance pattern of macrolides and FQ in campylobacters, especially C. jejuni and C. coli, in chickens and humans in several Governorates in Egypt as shown in Tables 2  and 3 [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] . Putnam [137] analyzed the annual prevalence of macrolides resistance rate in Cairo from 1995 till 2000, which was 0%. The first low level of resistance to macrolides (10% in C. coli and 9% in C. jejuni) was recorded in Cairo by Wasfy [138] . However, Putnam [137] did not record this resistance in the same Governorate. In 2006, marked increase in resistance level of macrolides was obviously observed in Mansoura Governorate (42.8%) by Omar [140] , While, no resistance was reported in Fayoum Governorate [139] . Recently, different studies reported higher resistance rates of C. jejuni and C. coli in samples obtained from chickens and humans, 94.7% in Cairo [142] , 83.3% in Zagazig [144] and 100% in Cairo, Giza, Kaliobia, Monefia, Fayoum and Zagazig [143, 145] . Although the resistance rate of FQ was 0% in 1991 [136] , the FQ resistance rates were early observed than macrolides [137] . Putnam [137] [145] and 92.9% in Cairo, Giza, Kaliobia, Monefia, Fayoum (for C. coli) [145] . Thus, the study of the resistance mechanisms in C. jejuni and C. coli is important for both humans and veterinary health.
Conclusion
In conclusion, the increase in FQ and macrolides resistance in campylobacters is documented in Egypt. Therefore, continuous and regular survey for resistance to these drugs is essential for control of infections, which in turn has an impact on human health and veterinary sectors.
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